Impact of Persistent Medication Adherence and Compliance with Lifestyle Recommendations on Major Cardiovascular Events and One-Year Mortality in Patients with Type 2 Diabetes and Advanced Stages of Atherosclerosis: Results From a Prospective Cohort Study
References
- Thorud JC, Plemmons B, Buckley CJ, Shibuya N, Jupiter DC. Mortality after nontraumatic major amputation among patients with diabetes and peripheral vascular disease: a systematic review. J Foot Ankle Surg. 2016; 55: 591–9. DOI: 10.1053/j.jfas.2016.01.012
- Shalaeva EV, Saner H, Janabaev BB, Shalaeva AV. Coronary artery calcium score and coronary computed tomographic angiography for major perioperative cardiovascular complications in symptomatic diabetic patients undergoing trans-femoral amputation. Int J Cardiol. 2016; 221: 806–11. DOI: 10.1016/j.ijcard.2016.06.165
- Abid A, Hosseinzadeh S. Foot Ulcer. Consultant. 2022; 41: 1521–6. DOI: 10.1002/9781119603238.ch8.2
- Shalaeva E, Bano A, Kasimov U, Janabaev B, Baumgartner I, Laimer M, et al. Coronary artery calcium score and coronary computed tomography angiography predict one-year mortality in patients with type 2 diabetes and peripheral artery disease undergoing partial foot amputation. Diabetes Vasc Dis Res. 2022; 19: 147916412211251. DOI: 10.1177/14791641221125190
- Sidikov A, Zaslavsky D, Sadykov A, Megna M, Garcia T, Aristizabal M, et al. The new differential diagnostic test for the lichenoid drug eruption. Dermatol Ther. 2020; 33. DOI: 10.1111/dth.13784
- World Health Organization. Diabetes fact sheets.
https://www.who.int/news-room/fact-sheets/detail/diabetes (accessed 2 July 2022). - Gregg EW, Hora I, Benoit SR. Resurgence in diabetes-related complications. JAMA. 2019; 321: 1867–8. DOI: 10.1001/jama.2019.3471
- Prevention and management of mental health conditions in Uzbekistan: the case for investment.
WHO/EURO: 2021-3827-43586-61232 . WHO Regional Office for Europe; 2021. Retrieved fromhttps://www.who.int/europe/publications/i/item/WHO-EURO-2021-3827-43586-61232 . - World Health Statistics. n.d. World Health Organization.
https://www.who.int/data/gho/publications/world-health-statistics (accessed August 3, 2023). - Madanchi N, Tabatabaei-Malazy O, Pajouhi M, Heshmat R, Larijani B, Mohajeri-Tehrani MR. Who are diabetic foot patients? A descriptive study on 873 patients. J Diabetes Metab Disord. 2013; 12. DOI: 10.1186/2251-6581-12-36
- Brownrigg JR, Apelqvist J, Bakker K, Schaper NC, Hinchliffe RJ. Evidence-based management of PAD & the diabetic foot. Eur J Vasc Endovasc Surg. 2013 Jun; 45(6): 673–81. DOI: 10.1016/j.ejvs.2013.02.014. Epub 2013 Mar 27. PMID: 23540807.
- Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019 Jan; 62(1): 3–16. DOI: 10.1007/s00125-018-4711-2. Epub 2018 Aug 31. PMID: 30171279.
- Thewjitcharoen Y, Sripatpong J, Krittiyawong S, Porramatikul S, Srikummoon T, Mahaudomporn S, et al. Changing the patterns of hospitalized diabetic foot ulcer (DFU) over a 5-year period in a multi-disciplinary setting in Thailand. BMC Endocr Disord. 2020; 20. DOI: 10.1186/s12902-020-00568-7
- Nursing Area. Preventing polypharmacy in older adults.
https://www.nursingarea.com/preventing-polypharmacy-in-older-adults/ (Accessed 10 July 2022). - Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42: 3227–337. DOI: 10.1093/eurheartj/ehab484
- FDA. Why You Need to Take Your Medications as Prescribed or Instructed.
https://www.fda.gov/drugs/special-features/why-you-need-take-your-medications-prescribed-or-instructed (Accessed 10 July 2022). - Waibel F, Berli M, Catanzaro S, Sairanen K, Schöni M, Böni T, et al. Optimization of the antibiotic management of diabetic foot infections: Protocol for two randomized controlled trials. Trials. 2020; 21. DOI: 10.1186/s13063-019-4006-z
- Degli Esposti L, Saragoni S, Batacchi P, Benemei S, Geppetti P, Sturani A, et al. Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis. Clin Ther. 2012; 34: 190–9. DOI: 10.1016/j.clinthera.2011.12.011
- Zhang Q, Safford M, Miller D, Crystal S, Rajan M, Tseng CL, et al. Short-term statin exposure is associated with reduced all-cause mortality in persons with diabetes. Med Care. 2007; 45: 308–14. DOI: 10.1097/01.MLR.0000250227.94196.F0
- Smith SM, Huo T, Delia Johnson B, Bittner V, Kelsey SF, Vido Thompson D, et al. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: A report from the NHLBI-sponsored WISE Study. J Am Heart Assoc. 2014; 3. DOI: 10.1161/JAHA.113.000660
- Schroeder SA. We can do better — improving the health of the american people. N Engl J Med. 2007; 357: 1221–8.
10.1056/NEJMSA073350/SUPPL_FILE/NEJM_SCHROEDER_1221SA1.PDF . DOI: 10.1056/NEJMsa073350 - Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020; 41: 255–323. DOI: 10.1093/eurheartj/ehz486
- CDC National Center for Health Statistics. National Health Interview Survey: Smoking Status Recodes. US Department of Health and Human Services.
https://www.cdc.gov/nchs/nhis/tobacco/tobacco_recodes.htm (Accessed 12 October 2022). - Neumann FJ, Sechtem U, Banning AP, Bonaros N, Bueno H, Bugiardini R, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41: 407–77. DOI: 10.1093/eurheartj/ehz425
- Yumuk V, Tsigos C, Fried M, Schindler K, Busetto L, Micic D, et al. European guidelines for obesity management in adults. Obes Facts. 2015; 8: 402–24. DOI: 10.1159/000442721
- Bakris G, Ali W, Parati G. ACC/AHA versus ESC/ESH on hypertension guidelines: JACC guideline comparison. J Am Coll Cardiol. 2019; 73: 3018–26. DOI: 10.1016/j.jacc.2019.03.507
- Messerli FH, Bavishi C, Brguljan J, Burnier M, Dobner S, Elijovich F, et al. Renal denervation in the antihypertensive arsenal – knowns and known unknowns. J Hypertens. 2022; 40: 1859–75. DOI: 10.1097/HJH.0000000000003171
- Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39: 3021–104. DOI: 10.1093/eurheartj/ehy339
- Shalaeva EV, Messerli FH. What is resistant arterial hypertension? Blood Press. 2023; 32. DOI: 10.1080/08037051.2023.2185457
- Frykberg RG. Diabetic foot ulcers: Pathogenesis and management. Am Fam Physician. 2002; 66(1): 1655–1662.
- Pevzner Diets. n.d.
- Baumgartner PC, Haynes RB, Hersberger KE, Arnet I. A systematic review of medication adherence thresholds dependent of clinical outcomes. Front Pharmacol. 2018; 9. DOI: 10.3389/fphar.2018.01290
- Prieto-Merino D, Mulick A, Armstrong C, Hoult H, Fawcett S, Eliasson L, et al. Estimating proportion of days covered (PDC) using real-world online medicine suppliers’ datasets. J Pharm Policy Pract. 2021; 14. DOI: 10.1186/s40545-021-00385-w
- Gómez-Pardo E, Fernández-Alvira JM, Vilanova M, Haro D, Martínez R, Carvajal I, et al. A comprehensive lifestyle peer group–based intervention on cardiovascular risk factors: The randomized controlled fifty-fifty program. J Am Coll Cardiol. 2016; 67: 476–85. DOI: 10.1016/j.jacc.2015.10.033
- Hupfeld C, Mudaliar S. Navigating the “MACE” in cardiovascular outcomes trials and decoding the relevance of atherosclerotic cardiovascular disease benefits versus heart failure benefits. Diabetes, Obes Metab. 2019; 21: 1780–9. DOI: 10.1111/dom.13740
- Messerli FH, Shalaeva EV., Rexhaj E. Optimal BP targets to prevent stroke and MI: Is there a lesser of 2 evils? J Am Coll Cardiol. 2021; 78: 1679–81. DOI: 10.1016/j.jacc.2021.09.013
- Merchant RM, Topjian AA, Panchal AR, Cheng A, Aziz K, Berg KM, et al. Part 1: Executive Summary: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020; 142: S337–57. DOI: 10.1161/CIR.0000000000000918
- Armstrong EJ, Chen DC, Westin GG, Singh S, McCoach CE, Bang H, et al. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease. J Am Heart Assoc. 2014; 3. DOI: 10.1161/JAHA.113.000697
- Knight SR, Ho A, Pius R, Buchan I, Carson G, Drake TM, et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: Development and validation of the 4C Mortality Score. BMJ. 2020; 370. DOI: 10.1136/bmj.m3339
- Shalaeva E V., Saner H, Janabaev BB, Shalaeva AV. Tenfold risk increase of major cardiovascular events after high limb amputation with non-compliance for secondary prevention measures. Eur Heart J. 2017; 24: 708–16. DOI: 10.1177/2047487316687103
- Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation. 2017; 135: e686–725. DOI: 10.1161/CIR.0000000000000470
- Iacopi E, Coppelli A, Riitano N, Abbruzzese L, Pieruzzi, L, Goretti, C, et al. Adherence to guideline recommended medical therapies in type 2 diabetic patients with chronic critical limb ischemia. Diabetes Res Clin Pract. 2019; 158. DOI: 10.1016/j.diabres.2019.107898
DOI: https://doi.org/10.5334/gh.1273 | Journal eISSN: 2211-8179
Language: English
Submitted on: Apr 21, 2023
Accepted on: Oct 5, 2023
Published on: Nov 1, 2023
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2023 Evgeniya V. Shalaeva, Arjola Bano, Ulugbek Kasimov, Bakhtiyor Janabaev, Markus Laimer, Hugo Saner, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.